ACCUMEN delivers results for hospitals and health systems in clinical laboratory operations, outreach, and patient blood management and transfusion safety. Using a proven blueprint, innovative customized approach, and proprietary technology, Accumen partners with hospitals and health systems on strategies to transform clinical laboratories and patient blood management programs from good to great in a fraction of the time most institutions would take to do it on their own.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

MEDICAL DEVICES

GENEQUANTUM HEALTHCARE'S TWO NEXT GENERATION BIOCONJUGATE DRUGS, GQ1005 AND GQ1007, HAVE BEEN APPROVED FOR CLINICAL TRIALS IN AUSTRALIA

GeneQuantum Healthcare | May 16, 2022

news image

GeneQuantum Healthcare Co., Ltd. a global innovative biotechnology company dedicated to the development of bioconjugate drugs, announced that two of the company's bioconjugate drug candidates have won the approval for clinical trials in Australia, further enhancing GeneQuantum's pipelines in the clinical stage. They are GQ1005, an ADC with an excellent bystander killing effect, and GQ1007, a first-in-class antibody-immune-agonist-conjugateboth with global intellectual property r...

Read More

HEALTHCARE VENTURE INVESTMENT IN 2020: QUANTUM COMPUTING GETS A CLOSER LOOK

Healthcare IT News | January 23, 2020

news image

Among the healthcare technologies venture firms be looking at most closely at in 2020, various artificial intelligence and machine learning applications are atop this list, of course. But so are more nuts-and-bolts tools like administrative process automation and patient engagement platforms, VCs say. Other, more leading-edge technologies – genomics-focused data and analytics, and even quantum computing – are among the areas attracting investor interest this year. We expect 2020 to m...

Read More

ACCENTURE SEES BIG HEALTH IT ROLES FOR AI AND EMERGING TECHNOLOGIES IN 2020

Healthcare IT News | January 31, 2020

news image

Accenture has a deep bench when it comes to healthcare expertise. And the consulting giant keeps a keen eye on healthcare information technology and the trends surrounding this IT. This is why Healthcare IT News turned to Accenture for its view of trends in health IT this year and beyond. Dr. Kaveh Safavi, senior managing director, head of global health practice, at Accenture, offers his analysis and predictions, focusing on AI and emerging technologies. Accenture recently polled healthcare exec...

Read More

HEALTH TECHNOLOGY

LEADING ACOS ARE CHOOSING INNOVACCER’S ACO REACH SOLUTION SUITE TO IMPROVE POPULATION HEALTH AND ADVANCE HEALTH EQUITY

Innovaccer Inc., | August 05, 2022

news image

Innovaccer Inc., the Health Cloud company, announced the expansion of its Solution Suite for ACO REACH participants. With its ACO REACH Solution Suite, Innovaccer has taken its entire portfolio of solutions that several leading ACOs across the country use, to help New Entrant ACOs and High Needs Population ACOs accelerate their transformation and advance health equity. Since the initial launch of the ACO REACH Solution Suite in April, Innovaccer has rapidly expanded its client base ...

Read More
news image

MEDICAL DEVICES

GENEQUANTUM HEALTHCARE'S TWO NEXT GENERATION BIOCONJUGATE DRUGS, GQ1005 AND GQ1007, HAVE BEEN APPROVED FOR CLINICAL TRIALS IN AUSTRALIA

GeneQuantum Healthcare | May 16, 2022

GeneQuantum Healthcare Co., Ltd. a global innovative biotechnology company dedicated to the development of bioconjugate drugs, announced that two of the company's bioconjugate drug candidates have won the approval for clinical trials in Australia, further enhancing GeneQuantum's pipelines in the clinical stage. They are GQ1005, an ADC with an excellent bystander killing effect, and GQ1007, a first-in-class antibody-immune-agonist-conjugateboth with global intellectual property r...

Read More
news image

HEALTHCARE VENTURE INVESTMENT IN 2020: QUANTUM COMPUTING GETS A CLOSER LOOK

Healthcare IT News | January 23, 2020

Among the healthcare technologies venture firms be looking at most closely at in 2020, various artificial intelligence and machine learning applications are atop this list, of course. But so are more nuts-and-bolts tools like administrative process automation and patient engagement platforms, VCs say. Other, more leading-edge technologies – genomics-focused data and analytics, and even quantum computing – are among the areas attracting investor interest this year. We expect 2020 to m...

Read More
news image

ACCENTURE SEES BIG HEALTH IT ROLES FOR AI AND EMERGING TECHNOLOGIES IN 2020

Healthcare IT News | January 31, 2020

Accenture has a deep bench when it comes to healthcare expertise. And the consulting giant keeps a keen eye on healthcare information technology and the trends surrounding this IT. This is why Healthcare IT News turned to Accenture for its view of trends in health IT this year and beyond. Dr. Kaveh Safavi, senior managing director, head of global health practice, at Accenture, offers his analysis and predictions, focusing on AI and emerging technologies. Accenture recently polled healthcare exec...

Read More
news image

HEALTH TECHNOLOGY

LEADING ACOS ARE CHOOSING INNOVACCER’S ACO REACH SOLUTION SUITE TO IMPROVE POPULATION HEALTH AND ADVANCE HEALTH EQUITY

Innovaccer Inc., | August 05, 2022

Innovaccer Inc., the Health Cloud company, announced the expansion of its Solution Suite for ACO REACH participants. With its ACO REACH Solution Suite, Innovaccer has taken its entire portfolio of solutions that several leading ACOs across the country use, to help New Entrant ACOs and High Needs Population ACOs accelerate their transformation and advance health equity. Since the initial launch of the ACO REACH Solution Suite in April, Innovaccer has rapidly expanded its client base ...

Read More